Results 251 to 260 of about 935,849 (402)

VIRAL AND CHLAMYDIAL ETIOLOGY OF ACUTE INFECTIONS OF THE LOWER RESPIRATORY TRACT IN COLOMBIAN PEDIATRIC PATIENTS [PDF]

, 1987
Jorge Duque, C W Henrfquez, A Villegas
openalex   +1 more source

Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Importance Leukodystrophies are a diverse group of rare disorders that disrupt central myelination. These disorders present with a broad spectrum of neurological severity and are associated with a range of potential secondary complications, such as scoliosis and failure of independent feeding.
Emma R. Kotes, Sarah Woidill, Russell D'Aiello, Amina Khan, Jacob McCann, Mark Ramos, Francesco Gavazzi, Stephanie Keller, Keith Van Haren, Ali Fatemi, Florian Eichler, Joshua Bonkowsky, Jamie Fraser, Lisa Emrick, Omar Sherbini, Ashley Hackett, Jeilo Gauna, Dandre Amos, Jordan Goodman, Amena Smith Fine, Amanda Nagy, Seungil Lee, Nicole Page, Johanna Schmidt, Amy Pizzino, Kayla Muirhead, Mariko Bennett, Amy Waldman, Justine Shults, Laura Adang, Robert Grundmeier, Adeline Vanderver   +31 more
wiley   +1 more source

Microbiological aetiology of paediatric respiratory tract infections in Kyrgyzstan. [PDF]

BMC Infect Dis
Osmonbaeva N, Bloch J, Erkinbaeva A, Tilebalieva A, Tolobekova R, Zhaparova M, Rogbo-Bengtsson A, Isaeva E, Akylbekov A, Mademilov M, Baltabaeva E, Esengeldieva G, Jensen CS, Nielsen ACY, Kirkby NS, Skov R, Poulsen A, Kjærgaard J, Sooronbaev T, Kurtzhals JAL.   +19 more
europepmc   +1 more source

Upper Respiratory Tract Infection

, 2009
openaire   +3 more sources

The Release of Leukotrienes in the Respiratory Tract during Infection with Respiratory Syncytial Virus: Role in Obstructive Airway Disease

, 1988
Benjamin Volovitz, Charles Welliver, Giovanna De Castro, D Krystofik, Pearay L. Ogra   +4 more
openalex   +1 more source

Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults

Clinical Pharmacology in Drug Development, EarlyView.
Abstract AZD7442, a combination of extended half‐life monoclonal antibodies tixagevimab and cilgavimab, was shown to neutralize previously circulating SARS‐CoV‐2 variants. This study evaluated safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD7442 in healthy Chinese adults. In this randomized, placebo‐controlled, Phase 1 study, AZD7442
Nanyang Li, Jing Zhang, Wenhong Zhang, Zhongyuan Xu, Xiangcao Yao, Anqi He, Shuyuan Liu, Xiaoyun Ge, Jinxi Liu, Yunfei Li, Cecil Chi‐Keung Chen, Huixia Zhang   +11 more
wiley   +1 more source

Profiles of viral pathogens from individuals with acute respiratory tract infections in northern Tanzania. [PDF]

IJID Reg
Mollel JS, Mziray SR, Ndaro A, Kituma E, Kamwamwa I, Mapunda L, Semvua H, Mpagama SG, Chilongola JO.   +8 more
europepmc   +1 more source

A survey of virus infections of the respiratory tract of cattle and their association with disease

, 1980
E. J. Stott, L.H. Thomas, A.P. Collins, S. Crouch, J. Jebbett, Graeme Smith, Peter Luther, Rachel J Caswell   +7 more
openalex   +1 more source

Thermal balance and metabolic rate during upper respiratory tract infection in infants. [PDF]

, 1994
Peter Fleming, Tia Howell, Mark Clements, Jane S. Lucas   +3 more
openalex   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

Clinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou, Rohit Rao, Monica E. Shapiro, Nessy Tania, Cody Herron, Cynthia J. Musante, Jim H. Hughes   +6 more
wiley   +1 more source